LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization

Zhenxing Liang(Sun Yat-sen University), Huashan Liu(Sun Yat-sen University), Fengwei Wang(Sun Yat-sen University), Li Xiong(Sun Yat-sen University), Chi Zhou(Sun Yat-sen University), Tuo Hu(Sun Yat-sen University), Xiaowen He(Sun Yat-sen University), Xiaojian Wu(Sun Yat-sen University), Dan Xie(Sun Yat-sen University), Xianrui Wu(Sun Yat-sen University), Ping Lan(Sun Yat-sen University)
Cell Death and Disease
November 4, 2019
Cited by 404Open Access
Full Text

Abstract

Metastasis is a well-known poor prognostic factor in cancer. However, the mechanisms how long non-coding RNAs (lncRNAs) regulate metastasis in colorectal cancer (CRC) remain largely unknown. Besides, tumor-associated macrophages (TAMs) play an important role in tumor progression, yet the contribution of lncRNA-mediated crosstalk between TAMs and CRC cells to tumor progression is not well understood. In this study, we report that lncRNA RPPH1 was significantly upregulated in CRC tissues, and the RPPH1 overexpression was associated with advanced TNM stages and poor prognosis. RPPH1 was found to promote CRC metastasis in vitro and in vivo. Mechanistically, RPPH1 induced epithelial-mesenchymal transition (EMT) of CRC cells via interacting with β-III tubulin (TUBB3) to prevent its ubiquitination. Furthermore, CRC cell-derived exosomes transported RPPH1 into macrophages which mediate macrophage M2 polarization, thereby in turn promoting metastasis and proliferation of CRC cells. In addition, exosomal RPPH1 levels in blood plasma turned out to be higher in treatment-naive CRC patients but lower after tumor resection. Compared to CEA and CA199, exosomal RPPH1 in CRC plasma displayed a better diagnostic value (AUC = 0.86). Collectively, RPPH1 serves as a potential therapeutic and diagnostic target in CRC.


Related Papers

No related papers found

Powered by citation graph analysis